• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

IVD Trends and Market Update, March 2022

$5,000.00 – $10,000.00

Clear
SKU: 22-028 Categories: Diagnostics Market Research, in vitro diagnostic, IVD Tags: COVID-19, in vitro diagnostics, ivd Pages: 52
  • Description
  • Table of Contents
  • Latest reports

Description

What’s Driving Growth in the IVD Market in 2022?

What Major Trends are Affecting the Market in 2022?

How Has COVID-19 Impacted and Continued to Impact the Market in 2022?

What Product Trends and New Developments Will Shape the IVD Market in 2022?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q1 2022.

The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.

Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Table of Contents

Chapter One: Worldwide IVD Market – March 2022 Update

IVD Market Demand and Growth

  • Figure 1-1: Quarter-by-Quarter Segment Performance Commentary, 2021
  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2021 ($ million) (Clinical Chemistry; Immunoassays – non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab; Hematology – Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology – Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
  • Figure 1-2: IVD Segment Performance, Q1 2021 – Q4 2021 ($MN)
  • Figure 1-3: IVD Segment Performance, Total Market Value, 2021 ($MN)

COVID-19 Diagnostic Markets

Effect of COVID-19 on Market Segments

  • Table 1-2: IVD Market excluding and with COVID-19, 2021
  • Figure 1-4: IVD Market Distribution by Segment
  • Table 1-3: Global In Vitro Diagnostic Market – YoY Growth 2020-2021
  • Figure 1-5: Global In Vitro Diagnostic Market – YoY Growth 2020-2021

 

Chapter Two: Product Trends and New Developments

Selected New – Q4 2021 and Q1 2022 – Core IVD Product Launches, Developments and Trends

Clinical Chemistry

Flow Cytometry

Immunoassay

Mass Spectrometry

Molecular

Personalized Medicine

POC

Sequencing

COVID-19 Developments – Q1 2021 Through Q4 2021

  • Figure 2-1: COVID-19 Test Market by Type, Q1-Q4 2021 Estimates – Rapid Testing Markets Remain Strong

Antigen

Molecular

 

Chapter Three: Top IVD Market Participant Results

Selected Competitive Leader Updates

  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2020-2021
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 & 2021 – Roche and Abbott Tie for #1 Spot

2021 M&A Activity

  • Table 3-1: IVD-Relevant M&A Activity, 2021
  • Figure 3-3: Count of IVD Industry M&A Deals by Month, 2021

Abbott Laboratories

  • Table 3-2: Abbott Corporate Summary
  • Figure 3-4: Abbott Diagnostics Revenue by Segment (Core Laboratory, Molecular, Point-of-Care, Rapid Diagnostics, COVID-19, BinaxNOW/ID NOW) Full Year 2020 and 2021

Becton Dickinson and Co

  • Table 3-3: Becton Dickinson Corporate Summary
  • Figure 3-5: BD Life Sciences, Revenues by Business FY End September 30, 2020, and 2021

bioMérieux SA

  • Table 3-4: bioMérieux Corporate Summary
  • Figure 3-6: bioMérieux Clinical Applications Segment, Full Year Results, 2020,2021

Danaher Corporation

  • Table 3-5: Danaher Corporation Summary
  • Figure 3-7: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021

Hologic, Inc.

  • Table 3-6: Hologic Corporate Summary
  • Figure 3-8: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M

Ortho Clinical Diagnostics

  • Table 3-7:  Ortho Clinical Corporate Summary
  • Figure 3-9: Ortho Clinical Diagnostics, Full Year Results, $M (2020, 2021)

PerkinElmer, Inc.

  • Table 3-8: Perkin Elmer Corporate Summary
  • Figure 3-10: PerkinElmer Diagnostics (Product, Service Revenue), Full Year Results, $M (2020, 2021)

Quidel Corporation

  • Table 3-9: Quidel Corporate Summary
  • Figure 3-11: Quidel Corporation Revenue by Product Group, Full Year Results 2020, 2021, $M

Roche Diagnostic

  • Table 3-10: Roche Diagnostic Corporate Summary
  • Figure 3-12: Roche Diagnostics Revenue by Product Group, Full Year Results 2020, 2021, CHF MN

Siemens Healthineers

  • Table 3-11: Siemens Healthineers Corporate Summary
  • Figure 3-13: Siemens Diagnostics Revenue, FY 2020 and FY 2021, € MN

Sysmex Corporation

  • Table 3-12:  Sysmex Corporate Summary
  • Figure 3-14: Sysmex Revenue by Product Segment, FY 2020, 2021 and 2022, JPY MN

Thermo Fisher Scientific

  • Table 3-13: Thermo Fisher Scientific Corporate Summary
  • Figure 3-15: Thermo Fisher Scientific COVID-19 Response Revenue, 2020 and 2021 by Quarter

 

Chapter Four: New Opportunities

Artificial Intelligence in the Lab

Multiplex and Syndromic Testing

Advancing Lateral Flow Technologies

Personalized Medicine

Point-of-Care

Mass Spectrometry-based COVID-19 Testing

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
IVD Procedure Volumes, 2021-2026The Market and Future Potential for Molecular Point of Care (POC), 2022
Scroll to top